FONT-SIZE Plus   Neg

Bio-Reference Labs. Posts Lower Q1 Profit - Quick Facts

Bio-Reference Laboratories Inc.'s (BRLI) first-quarter net income decreased to $7.36 million or $0.26 per share from $7.99 million or $0.28 per share last year.

The company recorded quarterly revenues of $149.92 million, a 23% increase over $121.66 million reported in the prior-year quarter.

On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.21 on $143.13 million revenue for the quarter. Analysts' estimates typically exclude one-time items.

Marc Grodman, MD, CEO, commented: "The milder than normal weather conditions, particularly in the Northeast, have contributed to the strength of our Q1 results when compared to our prior year results. However, and more importantly, the overall success of all our business units has been the primary reason for our strong financial results."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Visa Inc. (V) on Monday reported an increase in profit for the fourth quarter, as revenues jumped driven largely by increase in customer spending and inclusion of Europe business. Earnings and revenues trumped Wall Street expectations. Foster City, California-based Visa's fourth-quarter profit rose... As Sony Corp. prepares to launch the new PlayStation 4 Pro gaming console on November 10, several new games that are compatible with the console have also been confirmed for launch. Game developers are readying to provide PlayStation 4 Pro support for many games on PS4. Shares of Advaxis Inc. dropped more than 13 percent in pre-market activity before paring losses to just more than 5 percent after the company said that it was not able to complete the second stage of the Phase 2 GOG-0265 trial as designed due to a clinical hold that affected its clinical development programs last year.
comments powered by Disqus
Follow RTT